Search

Your search keyword '"Jayne, David"' showing total 2,698 results

Search Constraints

Start Over You searched for: Author "Jayne, David" Remove constraint Author: "Jayne, David"
2,698 results on '"Jayne, David"'

Search Results

1. Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine: Protocol for a Randomized, Double-Blind, Active-Controlled, Phase 3 Trial

3. Predictors of British Isles Lupus Assessment Group-based outcomes in patients with systemic lupus erythematosus: Analysis from the Systemic Lupus International Collaborating Clinics Inception Cohort

8. Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort

9. Financial Anxiety among College Students: The Role of Generational Status

13. The HAVEN study—hydroxychloroquine in ANCA vasculitis evaluation—a multicentre, randomised, double-blind, placebo-controlled trial: study protocol and statistical analysis plan

14. Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis

17. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort

20. Routine sterile glove and instrument change at the time of abdominal wound closure to prevent surgical site infection (ChEETAh): a model-based cost-effectiveness analysis of a pragmatic, cluster-randomised trial in seven low-income and middle-income countries

21. The Improved Kidney Risk Score in ANCA-Associated Vasculitis for Clinical Practice and Trials

22. Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial

23. Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study

25. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial

29. Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study

30. Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan

34. Valuing Health Gain from Composite Response Endpoints for Multisystem Diseases

39. #3076 A UK parallel cohort study on renal ANCA associated vasculitis outcomes for avacopan exposed and matched unexposed cohorts

40. #3108 Rituximab in adult-onset IgA vasculitis

41. #1356 Kidney phenotype in interstitial lung disease associated with ANCA-vasculitis: European Multicentre Study

43. #464 Survey results on the utility of the Renal Risk Score and Histopathological Classification of ANCA-glomerulonephritis

44. Description and cross-sectional analyses of 25,880 adults and children in the UK National Registry of Rare Kidney Diseases cohort

45. Corrigendum to “Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA–Associated Vasculitis.” Kidney Int. 2024;105(3):447–449

47. Study Protocol: The Use of Rituximab in Nephrotic Glomerulonephritis (TURING)

Catalog

Books, media, physical & digital resources